Ligand Pharmaceuticals | Passifs Courants



Current Liabilities Changement Date
Amgen USD 23.1B 2.79B 2024-12
Arrowhead Research USD 93.76M 9.41M 2024-12
Baxter International USD 6.51B 311M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Eli Lilly USD 28.38B 3.7B 2024-12
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Glaxosmithkline GBP 21.7B 238M 2024-12
Insmed USD 297.53M 38.34M 2024-12
Ionis Pharmaceuticals USD 309.32M 4.75M 2024-12
Ligand Pharmaceuticals USD 37.11M 12.34M 2024-12
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 28.42B 1.17B 2024-12
Pacira USD 309.92M 3.52M 2024-12
Pfizer USD 43B 216M 2024-12
Veracyte USD 78.63M 8.32M 2024-12



Ligand Pharmaceuticals Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.